Ponad 7000 publikacji medycznych!
Statystyki za 2021 rok:
odsłony: 8 805 378
Artykuły w Czytelni Medycznej o SARS-CoV-2/Covid-19

Poniżej zamieściliśmy fragment artykułu. Informacja nt. dostępu do pełnej treści artykułu
© Borgis - Nowa Stomatologia 4/2004, s. 176-179
Joële Luc1, Elżbieta Dybiżbańska2, Christine Roques3
Bactericidal and fungicidal activity of selected mouthrinses - an in vitro study
1Fonderephar, Toulouse, Francja
2z Zakładu Stomatologii Zachowawczej IS AM w Warszawie
Kierownik Zakładu: prof. dr hab. Maria Wierzbicka
3Laboratoire de Bacteriologie, Virologie et Microbiologie Industrielle, Toulouse, Francja



INTRODUCTION
Dental caries as well as periodontal diseases are disorders of bacterial origin. The microorganisms responsible for caries are bacteria of the Streptococcus mutans and Lactobacillus acidophilus species. Among the microorganisms considered pathogenic for the periodontium are Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Tannarella forsythensis, while Prevotella intermedia, Campylobacter rectus, Peptostreptococcus micros, Fusobacterium, Eubacterium and Treponema species, as well as yeast-like fungi, are classified as potentially pathogenic (1). The above mentioned bacteria are deposited on the tooth surface forming a biofilm, generally known as plaque. Plaque control plays a fundamental role in the prevention of dental caries and periodontitis. Despite of this, mechanical methods of plaque control are often insufficient, and the supplemental use of chemical agents is recommended. It is often the case that manual skills are deficient, in individuals with physical or mental handicap, as well as following oral surgical procedures (2, 3). The aim of chemical plaque control is to prevent the proliferation of microorganisms (bacteriostatic agents), or the eradication of the microorganisms already present in the biofilm, as well as the newcomers (bactericidal agents) (4). The most frequently used carrier of an antibacterial chemical agent is a mouthrinse. Other carriers used include toothpaste, sprays, irrigation liquids, chewing gum, lozenges and dental varnishes (5). Among the most frequently used substances in plaque control are chlorhexidine, belonging to the bis-biguanides, as well as cetylpiridinium chloride, a quaternary ammonium compound, phenolic compounds such as triclosan, oxidizing agents e.g. hydrogen peroxide, fluoride compounds e.g. a combination of fluoroamines and stannous fluoride, metal salts e.g. tin, zinc, and others e.g. hexetidine (5).
The effectiveness of the chemical agents used for plaque control has been assessed through in vitro and in vivo assays. For the in vitro studies bacteriological tests were used, which assess the minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) of the tested agents (4).
The aim of this study was an in vitro assessment of the bactericidal and fungicidal action of eight mouthrinses used in home oral hygiene, with reference to selected species of bacteria and yeast most frequently observed in dental caries and periodontitis.
MATERIALS AND METHODS
The tested mouthrinses are presented in Table 1. The bactericidal and fungicidal action of the rinses was evaluated with respect to standard strains of the following microorganisms: Streptococcus mutans CIP 103220T, Lactobacillus acidophilus CIP 7316T, Fusobacterium nucleatum CIP 101130T, Prevotella intermedia CIP 103607 and Actinobacillus actinomycetemcomitans CIP 52109, as well as Candida albicans IP 4872, originating from the microorganism collection of l´Institut Pasteur (Paris).
Table 1. Mouthrinses tested.
MouthrinseActive ingredientConcentration used
Corsodyl0.20% chlorhexidine digluconatepure
Eludril0.10% chlorhexidine digluconatediluted: 1:2, 1:3
Hextril/Oralden0.10% hexetidinepure
Meridolfluoroamines + 0.025% stannous fluoridepure
Tantum verde0.15% benzydamine hydrochloridediluted: 1:2
Alodont0.005% cetylpiridinium chloridepure
Lacalut0.20% chlorhexidine digluconate, aluminium lactate, betain pure
Plak out0,12% chlorhexidine digluconatepure
Bacterial suspensions were prepared directly prior to use in sterile, distilled water at a concentration of 108-109 bacteria/ml, whereas for C. albicans – at a concentration of 107/ml. Bactericidal and fungicidal action was determined using the „dilution-neutralization” method (European Standard). The test was conducted by adding 1 ml of the microorganism suspension to 9 ml of the tested solution. In order to stimulate conditions in vivo in which there is interaction with organic components 0.3% bovine albumin was added to the test tube. Contact time was 1 minute at a temperature of 32°C. Contact was interrupted by transferring 1 ml from the test tube into 9 ml of a neutralizing substrate (10% polysorbate, 2% saponin, 2% lecithin, 0,5% sodium thiosulfate, soy-tryptone broth). Following 10 minutes of neutralization, the remaining live microorganisms were counted by incubating 1 ml of the suspension in Schaedler´s agar substrate (in the case of S.mutans), agar MRS substrate (for L. acidophilus), or agar plus malt extract (for C. albicans). In the case of F. nucleatum, P. intermedia and A. actinomycetemcomitans, counts were performed by plating 100 ml on Columbia sheep blood agar. The cultures were incubated at a temperature of 37°C for 48-72 hours under anaerobic or aerobic conditions for the bacteria and at a temperature of 30°C for C.albicans. After that, the colonies were counted. All tests were done twice.
RESULTS

Powyżej zamieściliśmy fragment artykułu, do którego możesz uzyskać pełny dostęp.
Mam kod dostępu
  • Aby uzyskać płatny dostęp do pełnej treści powyższego artykułu albo wszystkich artykułów (w zależności od wybranej opcji), należy wprowadzić kod.
  • Wprowadzając kod, akceptują Państwo treść Regulaminu oraz potwierdzają zapoznanie się z nim.
  • Aby kupić kod proszę skorzystać z jednej z poniższych opcji.

Opcja #1

24

Wybieram
  • dostęp do tego artykułu
  • dostęp na 7 dni

uzyskany kod musi być wprowadzony na stronie artykułu, do którego został wykupiony

Opcja #2

59

Wybieram
  • dostęp do tego i pozostałych ponad 7000 artykułów
  • dostęp na 30 dni
  • najpopularniejsza opcja

Opcja #3

119

Wybieram
  • dostęp do tego i pozostałych ponad 7000 artykułów
  • dostęp na 90 dni
  • oszczędzasz 28 zł
Piśmiennictwo
1. Slots J.: Primer for antimicrobial therapy. J. Periodont. Res., 2000, 35, 108-114. 2. Ciancio SG.: Use of mouthrinses for professional indications. J. Clin. Periodontol., 1988, 15, 520-523. 3.Zanela NL. et al.: The influence of mouthrinses with antimicrobial solutions on the inhibition of dental plaque and on the levels of mutans streptococci in children. Pesqui. Odontol. Bras., 2002, 16, 101-106. 4.Addy M.:The use of antiseptics in periodontal therapy. W Lindhe J., Karring T., Lang NP.: Clinical periodontology and implant dentistry. Oxford, Blackwell Munksgaard 2003, 464-493. 5.Sreenivasan P., Gaffar A.: Antiplaque biocides and bacterial resistance: a review. J. Clin. Periodontol., 2002, 29, 965-974. 6.Maruniak J., et al.: The effect of 3 mouthrinses on plaque and gingivitis development. J. Clin. Periodontol., 1992, 19, 19-23. 7.Stanley A., et al.: The in vitro effects of chlorhexidine on subgingival plaque bacteria. J. Clin. Periodontol., 1989, 16, 259-264. 8.Hermant C., et al.: In vitro fungicidal activity of main antiseptic solutions used as mouthwash against gingival fungal strains in HIV infected patients. Med. Mal. Infect., 1997, 27, 715-718. 9.Luc J., et al.: Activite bactericide in vitro de 5 antiseptiques buccaux vis-a-vis des principaux germes impliques dans les affections bucco-dentaires. J. de Parodontologie 1991,10, 381-387. 10.Brecx M., et al.: Efficacy of Listerine, Meridol and chlorhexidine mouthrinses as supplements to regular tooth - cleaning measures. J. Clin. Periodontol., 1992, 19, 202-207. 11.Richter S., et al.: In vivo study of the efficacy of a mouthrinse containing 0,1% chlorhexidine digluconate. Dent. Med. Probl., 2003, 40, 29-36. 12. Jenkins S., et al.: Dose response of chlorhexidine against plaque and comparison with triclosan. J. Clin. Periodontol., 1994, 21, 250-255. 13.Riep BG., et al.: Comparative antiplaque effectiveness of an essential oil and an amine fluoride/stannous fluoride mouthrinse. J. Clin. Periodontol., 1999, 26, 164-168. 14.Gjermo P., et al.: The plaque - inhibiting capacity of 11 antibacterial compounds. J. Periodont. Res., 1970, 5, 102-109. 15.Moran J., et al.: Comparative effects of quaternary ammonium mouthrinses on 4-day plaque regrowth. J. Clin. Periodontol., 2000, 27, 37-40. 16.Keijser JA., et al.: Comparison of 2 commercially available chlorhexidine mouthrinses. J. Periodontol., 2003, 74, 214-218. 17.Smith RG., et al.: Comparative staining in vitro and plaque inhibitory properties in vivo of 0.12% and 0.2% chlorhexidine mouthrinses. J. Clin. Periodontol., 1995, 22, 613-617. 18.Herrera D., et al.: Differences in antimicrobial activity of four commercial 0,12% chlorhexidine mouthrinse formulations: an in vitro contact test and salivary bacterial counts study. J. Clin. Periodontol., 2003, 30, 307-314. 19.Collaert B., et al.: The effect of delmopinol rinsing on dental plaque formation and gingivitis healing. J. Clin. Periodontol., 1992, 19, 274-280. 20.Lucas GQ., Lucas ON.: Preventive action of short - term and long - term chlorhexidine rinses. Acta Odontol Latinoam 1999, 12, 45-58. 21.Etemadzadeh H., et al.: Effect on plaque growth and salivary micro-organisms of amine fluoride - stannous fluoride and chlorhexidine - containing mouthrinses. J. Clin. Periodontol., 1989, 16, 175-178. 22.Helms JA., et al.: Effects of chlorhexidine on human taste perception. Arch. Oral. Biol., 1995, 40, 913-920. 23.Slots J.: Efficient antimicrobial treatment in periodontal maintenance care. J. Am. Den. Assoc., 2000, 131, 1293-1303.
Nowa Stomatologia 4/2004
Strona internetowa czasopisma Nowa Stomatologia